
Breast Cancer Awareness Month
As part of our continued efforts to support impactful cancer research and foster scientific dialogue, MDPI is spotlighting breast cancer, which develops when abnormal cells in the breast grow and divide uncontrollably, forming a malignant tumour that can spread to nearby lymph nodes and other parts of the body. According to the World Health Organization (WHO), an estimated 2.4 million women were diagnosed with breast cancer worldwide in 2024, with approximately 694,000 deaths attributed to the disease. Breast cancer remains a significant global health concern, affecting women across all countries and increasingly with age.
Every October, Breast Cancer Awareness Month highlights the importance of breast health, early detection and support for individuals affected by the disease. Despite significant advances in diagnosis and treatment, breast cancer remains a major public health concern. Early detection, including through regular mammography screening, can improve the chances of successful treatment. Continued public education, access to screening services and timely, effective treatment remain essential to improving outcomes and reducing the burden of breast cancer.
By bringing together cutting-edge research and developing focused Special Issues, MDPI journals continue to facilitate knowledge exchange and highlight emerging advances in breast cancer research. These efforts support progress in understanding disease mechanisms, improving early detection and diagnostic approaches and advancing innovative therapeutic strategies, ultimately contributing to better patient outcomes and quality of life worldwide.

![]() |
![]() |
![]() |
![]() |

| Invited Speakers | |||
![]() |
![]() |
![]() |
![]() |
| Dr. Taro Takahara, Takahara Clinic Innovative Scan, Japan |
Prof. Dr. Faye Suk-Ying Tsang, School of Life Sciences, The Chinese University of Hong Kong, China |
Prof. Dr. Ali S. Arbab, Georgia Cancer Center, Augusta University, USA |
Dr. Dik van Gent, Department of Molecular Genetics, Erasmus University Medical Center, the Netherlands |
Register for this webinar for free here!

“Relevance of EGFR-HER2 Dual Inhibition in Breast Cancer”
by Vidhi Jain, Saloni Bage, Nitisha Dhiman, Shaifali Singh, Arpana Yadav, Daniela Brünnert, Devesh M. Sawant and Pankaj Goyal
Targets 2026, 4(1), 10; https://doi.org/10.3390/targets4010010
“Contrast-Enhanced Mammography as a Functional Biomarker in Breast Cancer: Correlation of Enhancement Patterns with Ki-67 and Histological Grade”
by Marina Balbino, Manuela Montatore, Federica Masino, Antonietta Ancona, Francesca Anna Carpagnano, Giulia Capuano, Riccardo Guglielmi and Giuseppe Guglielmi
Targets 2026, 3(3), 29; https://doi.org/10.3390/targets3030029
“The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies”
by Ali Hassan and Corinne Aubel
Cancers 2025, 17(13), 2232; https://doi.org/10.3390/cancers17132232
“Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis”
by Jhony A. De La Cruz-Vargas, Henry Gómez, Jesus E. Talavera, Cristhian Gonzales-Rospigliosi, Ariana Alessandra Córdova Salazar and Rafael Pichardo-Rodriguez
Curr. Oncol. 2025, 32(6), 344; https://doi.org/10.3390/curroncol32060344
“Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment”
by Sandhya Shukla, Arvind Kumar Shukla, Adarsha Mahendra Upadhyay, Navin Ray, Fowzul Islam Fahad, Arulkumar Nagappan, Sayan Deb Dutta and Raj Kumar Mongre
Onco 2025, 5(2), 27; https://doi.org/10.3390/onco5020027
“The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)”
by Franklin Eduardo Corea-Dilbert and Muhammad Zubair Afzal
Onco 2025, 5(2), 18; https://doi.org/10.3390/onco5020018
“Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies”
by Eduarda Carvalho, Sule Canberk, Fernando Schmitt and Nuno Vale
Cancers 2025, 17(17), 1102; https://doi.org/10.3390/cancers17071102
“Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells”
by Tânia Moura, Paula Laranjeira, Olga Caramelo, Ana M. Gil and Artur Paiva
Curr. Oncol. 2025, 32(3), 143; https://doi.org/10.3390/curroncol32030143
“Borderline Phyllodes Breast Tumors: A Comprehensive Review of Recurrence, Histopathological Characteristics, and Treatment Modalities”
by Fulvio Borella, Mauro Porpiglia, Niccolò Gallio, Chiara Cito, Lorenzo Boriglione, Giulia Capella, Paola Cassoni and Isabella Castellano
Curr. Oncol. 2025, 32(2), 66; https://doi.org/10.3390/curroncol32020066
“Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition”
by Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, Marzena Baran, Ewelina Gumbarewicz and Andrzej Stepulak
Cancers 2025, 17(2), 228; https://doi.org/10.3390/cancers17020228
“Harnessing Artificial Intelligence to Enhance Global Breast Cancer Care: A Scoping Review of Applications, Outcomes, and Challenges”
by Jolene Li Ling Chia, George Shiyao He, Kee Yuen Ngiam, Mikael Hartman, Qin Xiang Ng and Serene Si Ning Goh
Cancers 2025, 17(2), 197; https://doi.org/10.3390/cancers17020197

| “Advances in Triple-Negative Breast Cancer: From Development to Patient Outcomes” Guest Editor: Dr. Nalo Hamilton Submission deadline: 31 January 2027 |
“Recent Advances in Artificial Intelligence-Based Approaches for Breast Cancer” Guest Editor: Dr. Ashirbani Saha Submission deadline: 28 February 2027 |
![]() |
![]() |
| “Clinical Treatment and Prognosis of Breast Cancer” Guest Editors: Dr. Roxana Popescu and Dr. Ionut Marcel Cobec Submission deadline: 31 March 2027 |
“Contrast-Enhanced Imaging for Breast Cancer Detection and Management” Guest Editors: Dr. Enida Bufi, Dr. Alejandro Martin Sanchez, Dr. Matteo Sammarra and Dr. Angela Bucaro Submission deadline: 1 April 2027 |
![]() |
![]() |
| “Innovations in Gynecologic Oncologic and Breast Cancer Surgery” Guest Editors: Dr. Dimitrios Tsolakidis and Dr. Dimitrios Zouzoulas Submission deadline: 30 June 2027 |
“Prospective Studies on Radiation Therapy for Breast Cancer” Guest Editors: Dr. Michael Yassa and Dr. Tarek Hijal Submission deadline: 30 June 2027 |
![]() |
![]() |

![]() |
![]() |
















